Advocates Push For Separate Oncology Center At FDA To Regulate Cancer Drugs, Biologics, Devices

June 8, 2016 at 4:13 PM
A group of 28 cancer patient advocacy organizations, including the American Cancer Society and Friends of Cancer Research, pressed FDA to set up a standalone Oncology Center of Excellence that includes drug, biologics and device experts to handle reviews of products designed to treat cancer. Their letter to the agency Monday (June 6) follows a proposal by Friends of Cancer Research to reorganize the agency's centers from product specific to disease specific, and comes on as Vice President Joe Biden's...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.